The problem of antibiotic resistance represents a major public health challenge globally. This situation is particularly worrying among children in sub-Saharan Africa, where death rates associated with this phenomenon reach alarming levels, rising to 100 deaths per 100,000 people. These grim findings were brought to light by two studies carried out jointly by the University Hospitals of Geneva and the University of Geneva in Switzerland.
Doctor Noémie Wagner, specialist in pediatric infectious diseases at the University Hospitals of Geneva and co-author of these studies, underlines the urgency of acting in the face of this problem. Indeed, antibiotic resistance compromises the effectiveness of treatments and significantly increases the risk of death, particularly among the most vulnerable populations, such as children in sub-Saharan Africa.
In this context, it is imperative to strengthen policies for the prevention and fight against antibiotic resistance, by implementing concerted actions on an international scale. Raising awareness among healthcare professionals, educating patients and ensuring rational use of antibiotics are crucial measures to stem this phenomenon and preserve the effectiveness of these precious medications.
Furthermore, it is essential to invest in the research and development of new therapeutic alternatives, such as innovative therapies and personalized treatments, in order to diversify the management options for resistant infections. Collaboration between health actors, international institutions and civil society organizations is also essential to meet this major public health challenge.
In conclusion, antibiotic resistance represents a serious threat to population health, particularly in sub-Saharan Africa where children are particularly affected. Faced with this urgent problem, it is imperative to act in a concerted and proactive manner to preserve the effectiveness of antibiotics and guarantee quality care for all.